Suyapa F Ball, MS
Suyapa Ball
Constrained sites, prohibitive construction timelines, and urgent demands for operational research space are pushing institutions to rethink conventional delivery — and modular construction is proving to be a serious long-term infrastructure strategy, not a stopgap. United Therapeutics' experience scaling a pioneering research program through phased modular construction — from a startup vivarium unit to a permanent facility engineered for 30-year longevity — offers a replicable framework for institutions navigating similar pressures. Session leaders examine the real advantages in cost certainty, schedule compression, and sustainability performance, and address the permitting complexity and stakeholder misconceptions that remain the primary barriers to broader adoption.